Riggs Asset Managment Co. Inc. Crispr Therapeutics Ag Transaction History
Riggs Asset Managment Co. Inc.
- $359 Million
- Q4 2024
A detailed history of Riggs Asset Managment Co. Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Riggs Asset Managment Co. Inc. holds 400 shares of CRSP stock, worth $17,128. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400
Previous 400
-0.0%
Holding current value
$17,128
Previous $18,000
16.67%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding CRSP
# of Institutions
488Shares Held
64.1MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$384 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$374 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$163 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$119 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.75MShares$118 Million1.21% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.34B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....